Macrogenics MGNX
NASDAQ MGNX
$4.40 +0.15 (+3.53%)
At close: Sep 4, 2026 · 4:00 PM EDT

Macrogenics (MGNX) Retained Earnings (2012 - 2026)

Macrogenics (MGNX) posted quarterly Retained Earnings of -$1.3 billion for Q1 2026, down 5.81% year-over-year from -$1.4 billion in Q1 2025, and down 2.96% quarter-over-quarter from -$1.2 billion in Q4 2025.

Analysis

Macrogenics (MGNX) Retained Earnings (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has reported Retained Earnings for 15 consecutive years, with -$1.3 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, Retained Earnings fell 5.81% year-over-year to -$1.3 billion; the TTM figure through Mar 2026 stood at -$1.3 billion (down 5.81% YoY), while the FY2025 annual figure was -$1.2 billion, down 6.38% from the prior year.
  • Retained Earnings slipped to -$1.3 billion in Q1 2026 per MGNX's latest filing, from -$1.2 billion in the prior quarter.
  • Across five years, Retained Earnings topped out at -$1.0 billion in Q1 2022 and bottomed at -$1.3 billion in Q1 2026.
  • Historically, Retained Earnings has averaged -$1.2 billion across 5 years, with a median of -$1.2 billion in 2024.
  • Annual changes were most pronounced in 2022 — Retained Earnings retreated 26.4% — and 2023, when it grew 4.5%.
  • Macrogenics' Retained Earnings stood at -$1.1 billion in 2022, then slipped by 0.83% to -$1.1 billion in 2023, then retreated by 6.07% to -$1.2 billion in 2024, then decreased by 6.38% to -$1.2 billion in 2025, then declined by 2.96% to -$1.3 billion in 2026.
  • Business Quant data shows MGNX's Retained Earnings at -$1.3 billion in Q1 2026, -$1.2 billion in Q4 2025, and -$1.2 billion in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Macrogenics 284.90 Mn 171.00 Mn - -1.26 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.26 Bn
Mar 31, 2026 -1.28 Bn
Dec 31, 2025 -1.24 Bn
Sep 30, 2025 -1.23 Bn
Jun 30, 2025 -1.25 Bn
Mar 31, 2025 -1.21 Bn
Dec 31, 2024 -1.17 Bn
Sep 30, 2024 -1.15 Bn
Jun 30, 2024 -1.21 Bn
Mar 31, 2024 -1.15 Bn
Dec 31, 2023 -1.10 Bn
Sep 30, 2023 -1.06 Bn
Jun 30, 2023 -1.07 Bn
Mar 31, 2023 -1.13 Bn
Dec 31, 2022 -1.09 Bn
Sep 30, 2022 -1.11 Bn
Jun 30, 2022 -1.08 Bn
Mar 31, 2022 -1.04 Bn
Dec 31, 2021 -973.94 Mn
Sep 30, 2021 -915.91 Mn